
Pembrolizumab - NCI - National Cancer Institute
Pembrolizumab works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system. This allows the immune …
Keytruda (pembrolizumab): Side effects, uses, cost, and more
Aug 21, 2025 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.
Keytruda: Side Effects, Uses, Cost, and More - Healthline
Oct 13, 2025 · Learn about cost, uses, and more of Keytruda (pembrolizumab). It's a prescription drug that treats certain cancers in adults and some children.
How KEYTRUDA® (pembrolizumab) Works
How KEYTRUDA and chemotherapy work For certain types of cancer, KEYTRUDA is approved to be used along with chemotherapy. See the list of indications for KEYTRUDA below, and ask your doctor …
Keytruda (pembrolizumab) - Uses, Side Effects, and More
Dec 18, 2024 · Overview: Keytruda is used to treat many types of cancer. The medicine helps to turn on the body's immune system, so it can attack cancer cells. Common side effects of Keytruda include …
Keytruda (pembrolizumab): Cancer Chemo Drug Uses & Side Effects
Keytruda (pembrolizumab) is a cancer chemotherapy drug that treats melanoma, lung cancer, and a host of other malignancies. It is often used in combination with other chemotherapy agents, …
Keytruda: What to Expect, Side Effects, and More
Oct 29, 2025 · Keytruda (chemical name: pembrolizumab) is an immunotherapy used to treat some types of triple-negative, MSI-H, dMMR, and TMB-H breast cancer.
What Does Keytruda Do? Understanding the Role of Pembrolizumab …
Mar 23, 2025 · What type of cancer does Keytruda treat particularly well? In clinical trials, the drug has demonstrated high efficacy in tumors with high tumor mutation burden (TMB), suggesting a role for …
Pembrolizumab (Keytruda) - Cancer Research UK
Pembrolizumab is a type of immunotherapy. It is a treatment for a number of different types of cancer such as melanoma. Find out about how you have it, possible side effects and other important …
Keytruda Receives 40th FDA Approval - Cancer Research Institute
Jun 21, 2024 · Merck's Keytruda (pembrolizumab) has achieved its 40th FDA approval, solidifying its role as a vital treatment option in oncology.